Stanford-backed accelerator StartX has partnered with QB3 to open a new life sciences laboratory called, aptly, “StartX-QB3 Labs.” It’s the first research space that’s both close to Stanford and is focused on that bench-to-bedside approach of bringing entrepreneurs from academia to industry.
The new, 2,000-square-foot space will be able to house up to 20 life science startups. The new space is already about 25 percent booked up with companies like Nirmidas Biotech, a maker of increased-sensitivity fluorescent diagnostic material, and Carmenta Biosciences, which is developing a diagnostic test for preeclampsia.
It’s meant to be convenient for Stanford entrepreneurs who play dual roles as faculty or students, and find it hard to truck over to San Francisco or the East Bay to conduct experiments and build their companies.
“Life science entrepreneurs are faced with extremely complex challenges in building their companies,” Andrew Lee, co-founder of StartX Med and founder of StartX-QB3 Labs, said in a statement. “Our facility will enable medical technology founders to focus on their core research and business development in a supportive environment, while avoiding the obstacles in sourcing, outfitting, and maintaining a high quality lab space.”
The lab is still accepting applications from early-stage life science, medical device, hardware and chemistry companies, it said in the statement.
